摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-3-amino-5-(4-methoxybenzylidene)-2-thioxothiazolidin-4-one | 160757-26-6

中文名称
——
中文别名
——
英文名称
(Z)-3-amino-5-(4-methoxybenzylidene)-2-thioxothiazolidin-4-one
英文别名
(5Z)-3-amino-5-[(4-methoxyphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
(Z)-3-amino-5-(4-methoxybenzylidene)-2-thioxothiazolidin-4-one化学式
CAS
160757-26-6
化学式
C11H10N2O2S2
mdl
——
分子量
266.345
InChiKey
OMBVNFXWGGZJGQ-TWGQIWQCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    113
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    氯甲酸丁酯(Z)-3-amino-5-(4-methoxybenzylidene)-2-thioxothiazolidin-4-one三甲基铝 作用下, 生成 3--5-(4-methoxybenzyliden)-2-thioxo-thiazolidin-4-on
    参考文献:
    名称:
    3-氨基若丹宁上的区域选择性缩合和 N-酰化
    摘要:
    3-氨基若丹宁与醛在3-氨基或5-亚甲基上进行区域选择性缩合。3-氨基官能团可以用羧酸氯化物或酸酐进行酰化。
    DOI:
    10.1002/ardp.19933261109
  • 作为产物:
    描述:
    N-氨基绕丹宁4-甲氧基苯甲醛 作用下, 以 乙醇 为溶剂, 以78%的产率得到(Z)-3-amino-5-(4-methoxybenzylidene)-2-thioxothiazolidin-4-one
    参考文献:
    名称:
    3-氨基-5-芳基-罗丹宁的溶剂控制区域选择性合成作为人碳酸酐酶的新型抑制剂
    摘要:
    通过绿色方法从 C5 位而不是更亲核的 3-NH 2 -Rh ( 1 ) 的 NH 2进行区域选择性功能化是一个挑战。本研究的主要目标是开发在无催化剂条件下3-NH 2 -Rh ( 1 ) 与NH 2游离罗丹宁( 1 ) 的溶剂促进和控制的区域选择性键烷基化反应。在水作为溶剂的情况下,3-NH 2 -Rh ( 1 ) 与醛的C5-加成芳基化反应有效地产生了C5-芳基化-罗丹宁(5-Ar-Rhs)。另一方面,在乙醇中使用催化量的酸催化剂,3-NH 的反应2 -Rh ( 1 ) 和醛类导致罗丹宁在 NH 位芳基化。水在反应中起两个作用:将 3-NH 2 -Rh ( 1 ) 转化为双齿亲核试剂和激活 3-NH 2 -Rh ( 1 ) 的 C-5 位以通过氢键簇实现 Knoevenagel 缩合。由于水和 3-NH 2 -Rh ( 1 ) 的氨基之间的氢键簇, 3-NH 2 -Rh ( 1 ) 充当
    DOI:
    10.1016/j.tet.2022.132896
点击查看最新优质反应信息

文献信息

  • NS5B HCV polymerase inhibitors
    申请人:Tularik Inc.
    公开号:US20020142290A1
    公开(公告)日:2002-10-03
    Compounds, compositions and methods are provided that are useful in the treatment and prevention of certain viral infections and associated diseases. In particular, the compounds of the invention inhibit the activity of a viral RNA polymerase. The subject methods are particularly useful in the treatment of diseases causes by hepatitis C virus infection.
    提供了一些在治疗和预防特定病毒感染和相关疾病中有用的化合物、组合物和方法。具体来说,本发明的化合物抑制了病毒RNA聚合酶的活性。这些方法特别适用于治疗由丙型肝炎病毒感染引起的疾病。
  • Synthesis of 2,3-dihydropyrazolo[5,1-<i>b</i>]thiazoles<i>via</i>a tandem condensation sulfur-extrusion reaction
    作者:Wolfgang Hanefeld、Martin Schlitzer
    DOI:10.1002/jhet.5570310675
    日期:1994.11
    2,3-Dihydropyrazolo[5,1-b]thiazoles 3 are the first representatives of a heterocyclic system, which are conveniently prepared by heating 3-aminorhodanines 1 with ethyl 2-bromo-3,3-diethoxypropionate (2), via a tandem condensation-sulfur extrusion reaction.
    2,3-二氢吡[5,1- b ]噻唑类3是杂环系统的第一代表,其可方便地通过加热制备的3- aminorhodanines 1与2-溴-3,3- diethoxypropionate(2),经由一串联缩合-硫挤出反应。
  • SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase
    作者:Jay P. Powers、Derek E. Piper、Yang Li、Veronica Mayorga、John Anzola、James M. Chen、Juan C. Jaen、Gary Lee、Jinqian Liu、M. Greg Peterson、George R. Tonn、Qiuping Ye、Nigel P. C. Walker、Zhulun Wang
    DOI:10.1021/jm050859x
    日期:2006.2.1
    Novel non-nucleoside inhibitors of the HCV RNA polymerase (NS5b) with sub-micromolar biochemical potency have been identified which are selective for the inhibition of HCV NS5b over other polymerases. The structures of the complexes formed between several of these inhibitors and HCV NS5b were determined by X-ray crystallography, and the inhibitors were found to bind in an allosteric binding site separate from the active site. Structure-activity relationships and structural studies have identified the mechanism of action for compounds in this series, several of which possess drug-like properties, as unique, reversible, covalent inhibitors of HCV NS5b.
  • Exploration of inhibitors for diaminopimelate aminotransferase
    作者:Chenguang Fan、Matthew D. Clay、Michael K. Deyholos、John C. Vederas
    DOI:10.1016/j.bmc.2010.02.001
    日期:2010.3
    Bacteria and higher plants make L-lysine from diaminopimelic acid (DAP). In mammals L-lysine is an essential amino acid that must be acquired from the diet as the biosynthetic pathway is absent for this key constituent of proteins. Recently, LL-diaminopimelate aminotransferase (LL-DAP-AT), a pyridoxal-5'-phosphate (PLP)-dependent enzyme, was reported to catalyze a key step in the route to L-lysine in plants and Chlamydia. Specific inhibitors of this enzyme could thus potentially serve as herbicides or antibiotics that are non-toxic to mammals. In this work, 29,201 inhibitors were screened against LL-DAP-AT and the IC50 values were determined for the top 46 compounds. An aryl hydrazide and rhodanine derivatives were further modified to generate 20 analogues that were also tested against LL-DAP-AT. These analogues provide additional structure-activity relationships (SAR) that are useful in guiding further design of inhibitors. (C) 2010 Elsevier Ltd. All rights reserved.
  • Hanefeld Wolfgang, Schlitzer Martin, Arch. Pharm, 326 (1993) N 11, S 887-891
    作者:Hanefeld Wolfgang, Schlitzer Martin
    DOI:——
    日期:——
查看更多